Top 10 Big Biopharma Companies (Large Pharma & Large Biotech) in the US in 2021 by Revenues

Johnson & Johnson, Pfizer Inc, AbbVie Inc, Merck & Co Inc, and Bristol-Myers Squibb Co are the top 5 big biopharma companies (Large Pharma & Large Biotech) in the US in 2021 by revenue. Collectively, the top 10 Big Biopharma companies (Large Pharma & Large Biotech) in the US generated revenue of $469,497 million, the highest revenue was generated by Johnson & Johnson ($93,775 million), followed by Pfizer Inc ($81,288 million) and AbbVie Inc ($56,197 million), while Moderna Inc ($18,471 million) stood the lowest. Johnson & Johnson is one of the leading biopharma companies in the US in 2021. The company research develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; consumer products in oral care, baby care, beauty, over-the-counter (OTC) medicines, women’s health, and wound care categories. The company classifies its business into three segments, Consumer Health: Pharmaceutical, and Medical Devices, and conducts its business through more than 260 operating companies in over 60 countries globally with 141,700 employees. Pfizer Inc is another leading biopharma company in the US in 2021. The company discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic, and pain, women’s health, cancer, inflammation, immune disorders, and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs), and contract manufacturing services. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. The company provides its products in North America, South America, Asia-Pacific, Australia, Europe, Africa, and the Middle East.